Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cytomegalovirus (CMV) elicits long-term T-cell immunity of unparalleled strength, which has allowed the development of highly protective CMV-based vaccine vectors. Counterintuitively, experimental vaccines encoding a single MHC-I restricted epitope offered better immune protection than those expressing entire proteins, including the same epitope. To clarify this conundrum, we generated recombinant murine CMVs (MCMVs) encoding well-characterized MHC-I epitopes at different positions within viral genes and observed strong immune responses and protection against viruses and tumor growth when the epitopes were expressed at the protein C-terminus. We used the M45-encoded conventional epitope HGIRNASFI to dissect this phenomenon at the molecular level. A recombinant MCMV expressing HGIRNASFI on the C-terminus of M45, in contrast to wild-type MCMV, enabled peptide processing by the constitutive proteasome, direct antigen presentation, and an inflation of antigen-specific effector memory cells. Consequently, our results indicate that constitutive proteasome processing of antigenic epitopes in latently infected cells is required for robust inflationary responses. This insight allows utilizing the epitope positioning in the design of CMV-based vectors as a novel strategy for enhancing their efficacy.

Original publication




Journal article


PLoS pathogens

Publication Date





e1006072 - e1006072


Department of Vaccinology, Helmholtz Centre for Infection Research, Braunschweig, Germany.


CD8-Positive T-Lymphocytes, Animals, Mice, Muromegalovirus, Herpesviridae Infections, Peptides, Vaccines, Synthetic, Viral Proteins, Viral Vaccines, Antigens, Viral, Epitopes, T-Lymphocyte, Immunodominant Epitopes, Chromatography, Liquid, Flow Cytometry, Mutagenesis, Site-Directed, Lymphocyte Activation, Immunologic Memory, Mass Spectrometry